Why Cronos Group Shares Rose Despite Worse-Than-Expected Q1 Results
Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights Cronos Group (NASDAQ:CRON) bolted out of the gate this year, with its shares quickly skyrocketing more than 120% by early February. Most of those gains have evaporated over the...
Source: fool.com